This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Nov;7(4):199-206.

Chemotherapy of renal cell carcinoma: 1983-1989

A Yagoda¹

Affiliations

PMID: 2694257

Review

Chemotherapy of renal cell carcinoma: 1983-1989

A Yagoda. Semin Urol. 1989 Nov.

. 1989 Nov;7(4):199-206.

Author

A Yagoda¹

Affiliation

¹ Division of Urology, Cornell University Medical College, New York, NY.

PMID: 2694257

No abstract available

PubMed Disclaimer

Similar articles

Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
Yagoda A, Abi-Rached B, Petrylak D. Yagoda A, et al. Semin Oncol. 1995 Feb;22(1):42-60. Semin Oncol. 1995. PMID: 7855619 Review. No abstract available.
Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
Yagoda A. Yagoda A. Prog Clin Biol Res. 1990;350:227-41. Prog Clin Biol Res. 1990. PMID: 2201045 Review. No abstract available.
Another step toward the cure of metastatic renal cell carcinoma?
Vogelzang NJ. Vogelzang NJ. J Clin Oncol. 2010 Dec 1;28(34):5017-9. doi: 10.1200/JCO.2010.31.5044. Epub 2010 Oct 25. J Clin Oncol. 2010. PMID: 20975069 No abstract available.
[Clinical results of Nexavar for the treatment of kidney cancer].
Escudier B. Escudier B. Prog Urol. 2007 Feb;17(1 Suppl 1):150-3. Prog Urol. 2007. PMID: 17571640 Review. French. No abstract available.
Outcomes and prognosis in advanced renal cell carcinoma.
Galsky MD, Vogelzang NJ. Galsky MD, et al. Expert Rev Anticancer Ther. 2007 Jun;7(6):839-45. doi: 10.1586/14737140.7.6.839. Expert Rev Anticancer Ther. 2007. PMID: 17555394 Review.

See all similar articles

Cited by

Current status of cytokine therapy in management of patients with metastatic renal cell carcinoma.
Kapoor AK, Hotte SJ. Kapoor AK, et al. Can Urol Assoc J. 2007 Jun;1(2 Suppl):S28-33. doi: 10.5489/cuaj.65. Can Urol Assoc J. 2007. PMID: 18542782 Free PMC article.
Effects of cytokines on growth in vitro of primary human renal cell carcinoma.
de Riese W, Allhoff EP, Werner M, Stief CG, Liedke S, Kirchner H, Atzpodien J. de Riese W, et al. Urol Res. 1992;20(5):369-73. doi: 10.1007/BF00922751. Urol Res. 1992. PMID: 1280874
Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients.
Philip T, Negrier S, Lasset C, Coronel B, Bret M, Blay JY, Merrouche Y, Carrie C, Kaemmerlen P, Chauvin F, et al. Philip T, et al. Br J Cancer. 1993 Nov;68(5):1036-42. doi: 10.1038/bjc.1993.476. Br J Cancer. 1993. PMID: 8217594 Free PMC article.
High incidence of asymptomatic brain lesions in metastatic renal cell carcinoma.
Seaman EK, Ross S, Sawczuk IS. Seaman EK, et al. J Neurooncol. 1995;23(3):253-6. doi: 10.1007/BF01059958. J Neurooncol. 1995. PMID: 7673989 Clinical Trial.
Tumors of the kidney, ureter, and bladder.
See WA, Williams RD. See WA, et al. West J Med. 1992 May;156(5):523-34. West J Med. 1992. PMID: 1595278 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information